Rare gene variants linked to inflammatory bowel disease

(Medical Xpress) -- An international team of scientists, including researchers from Karolinska Institutet, have identified several rare gene variants that predispose to IBD (Inflammatory Bowel Disease). The study provides new insights into disease pathogenesis, and suggests next-generation sequencing may speed hoped-for personalized treatment of common complex disorders.

Common chronic diseases such as , hypertension, obesity, diabetes, asthma, rheumatoid arthritis, inflammatory bowel disease and many others show , and hundreds of have been recently identified. DNA variants associated with modestly increased risk can be frequently found in the general population, but the pathogenetic relevance of rare genetic changes is often unknown in these complex disorders.

Accurate sequencing of the entire has become feasible with the recent advent of next-generation sequencing, and a large International team of scientists, including researchers from Karolinska Institutet, have now used this approach to seek for rare DNA variants in 56 genes known to predispose to Crohn's disease (CD), one of the two major forms of IBD together with ulcerative colitis. In their study, the genomic regions containing these genes have been re-sequenced in 350 Crohn's disease patients and 350 healthy controls, and several newly identified rare variants further tested for their risk effects in 16054 Crohn's disease patients, 12153 ulcerative colitis patients and 17575 controls from different countries.

"The results suggest that, even in the same gene, rare and common DNA variants are both important in determining one's risk to , with rare variants possibly more deleterious", says Associate Professor Mauro D'Amato at the Department of Biosciences and Nutrition, Karolinska Institutet, who led the Swedish part of the investigation. "This observation, should it become commonplace in complex diseases, may mean additional variants are to be routinely searched for in individual patients. With the cost of human genome sequencing rapidly decreasing, we should be well equipped for future clinical applications and improved diagnostics."

Crohn's disease and ulcerative colitis manifest as chronic inflammation of the gastrointestinal tract, with life-long symptoms including abdominal pain, diarrhea, rectal bleeding, ulcers, weight loss and debility. More than 1% of the general population is affected, there is currently no cure and surgery is often necessary in the most severe cases.

The study was published in the top-ranking journal Nature Genetics, and stems from an International collaboration of several laboratories in Europe and USA, and the contribution of the International IBD Genetic Consortium (IIBDGC). Corresponding authors are Dr Manuel Rivas and Associate Professor Mark Daly from the Broad Institute of Harvard and MIT in the US.

More information: Rivas MA, Beaudoin M, Gardet A, et al., Nature Genetics (2011) online 9 October.

Related Stories

30 new gene variants linked to Crohn's disease

Nov 22, 2010

An international team of scientists, including researchers from Karolinska Institutet, Sweden, have found 30 new gene variants associated with the risk of Crohns disease. The results of the study provide valuable insight ...

New genetic markers for ulcerative colitis identified

Jan 04, 2009

An international team led by University of Pittsburgh School of Medicine researchers has identified genetic markers associated with risk for ulcerative colitis. The findings, which appear today as an advance online publication ...

Research team identifies genes linked to ulcerative colitis

Mar 17, 2010

A study of the human genome led by Cedars-Sinai researchers has now identified genes linked to ulcerative colitis, offering clues as to what causes the condition and potential avenues for new therapies to treat the disease.

Recommended for you

Ontario has one of the highest rates of IBD in the world

Aug 28, 2014

One in every 200 Ontarians has been diagnosed with inflammatory bowel disease (IBD), with the number of people living with the disease increasing by 64 per cent between 1999 and 2008, according to a study by researchers at ...

New drug promises relief for inflammatory pain

Aug 27, 2014

Pain from inflammation sidelines thousands of Americans each year. Many face a tough choice: deal with the pain, take a potentially addictive opioid or use a nonsteroidal anti-inflammatory drug that may increase risk for ...

Overweight causes hazardous inflammations

Aug 25, 2014

Researchers have found a possible molecular explanation for why overweight is harmful. This new knowledge may provide new drugs for heart attack, stroke, cancer and chronic intestinal inflammation.

Asthma outcomes worse in older women

Aug 21, 2014

(HealthDay)—Older women face increased challenges in managing their asthma, according to a review published in the August issue of the Annals of Allergy, Asthma & Immunology.

User comments